Serum sickness

Last updated: December 18, 2025

Serum sickness

Watch later

Watch later

Thymus histology
Spleen histology
Lymph node histology
Introduction to the immune system
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Anergy, exhaustion, and clonal deletion
Vaccinations
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Sepsis
Neonatal sepsis
Abscesses
Food allergy
Anaphylaxis
Asthma
Immune thrombocytopenia
Autoimmune hemolytic anemia
Hemolytic disease of the newborn
Rheumatic heart disease
Myasthenia gravis
Graves disease
Pemphigus vulgaris
Serum sickness
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
Graft-versus-host disease
Contact dermatitis
Transplant rejection
Cytomegalovirus infection after transplant (NORD)
Post-transplant lymphoproliferative disorders (NORD)
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Common variable immunodeficiency
IgG subclass deficiency
Hyperimmunoglobulin E syndrome
Isolated primary immunoglobulin M deficiency
Thymic aplasia
DiGeorge syndrome
Severe combined immunodeficiency
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Chronic granulomatous disease
Complement deficiency
Hereditary angioedema
Asplenia
Thymoma
Ruptured spleen
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Glucocorticoids

Transcript

Watch video only

Let's imagine for a minute that you found yourself in the somewhat unfavorable position of having been bitten by a venomous snake.

Now, to treat that, you might get injected with anti-venom, which is the serum, or just the liquid part of blood and it’s had the coagulation proteins removed, and it comes from another animal, like a mouse, and that mouse has already encountered that particular venom and so it’s developed antibodies against it. These antibodies can bind to the venom molecules and render them harmless.

Now normally that's the end of that, but in serum sickness, your immune system actually mounts an attack against the foreign serum. It’s just like attacking a friendly police officer that’s trying to help you out. Serum sickness is a type III hypersensitivity reaction, which means that it’s mediated by immune complexes, which are combinations of antibodies and soluble antigens, in this case the antigens are the foreign antibodies in the serum.

Now normally, antibodies, which are sometimes called immunoglobulins, are produced by plasma cells, which are fully mature and differentiated B cells. B cells have multiple IgM antibodies on their surface and they act like receptors. When an antigen binds to two of these receptors it’s called cross-linking. This triggers the B cell to take in the antigen, break it all apart, and present a piece on the surface on a protein called MHC class II, which stands for major histocompatibility complex class II. Nearby T helper cells can then bind to the MHC class II protein via their T cell receptor, this happens along with costimulatory molecule CD4.

The B cell’s CD40 also binds to the T cell’s CD40 ligand, and that causes the T cell to release cytokines, which then results in B cell activation and class switching, or isotype switching. This means that it changes from producing IgM antibodies to producing IgG antibodies instead.

After class switching, B cells become plasma cells and they focus on producing large amounts of this IgG antibody. If this situation was an immune response to a pathogen like a bacterium, the IgG antibodies would bind to the antigen on the bacterium and mark it for destruction by macrophages and neutrophils.

In serum sickness, however, plasma cells start producing IgG antibodies in response to the antibodies in foreign serum that gets mistaken for a harmful antigen. This process all starts with the initial exposure to the foreign antibodies which triggers the B cells to become plasma cells and produce IgG antibodies against the foreign antibodies; and this all usually takes 4 to 10 days. If there are still foreign antibodies around, the IgG will bind to them and form immune complexes.

Key Takeaways

Serum sickness is a type III hypersensitivity reaction in which a foreign blood serum causes an allergy-like response. This happens when small, soluble foreign serum, elicits the production of antibodies, and those antigens and antibodies bind together to form immune complexes. These immune complexes then build up on the basement membrane of blood vessels in various parts of the body, and then the complement system is activated and this causes inflammation in and damage to nearby tissues. Symptoms include fever, urticaria, arthralgia, proteinuria, and lymphadenopathy. The treatment for serum sickness is generally to use antihistamines and analgesics which help with symptoms and to avoid the serum that triggered the reaction in the future.

Sources

  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Robbins Basic Pathology" Elsevier (2017)
  5. "Serum sickness-like reaction associated with cefazolin" BMC Clinical Pharmacology (2006)
  6. "Serum Sickness" Encyclopedia of Immunology (1998)
  7. "Serum Sickness" Pediatric Clinical Advisor (2007)
  8. "Serum Sickness" Pediatric Emergency Medicine (2008)